Your session is about to expire
← Back to Search
Exercise Prehabilitation for Pancreatic Cancer (PREHAB Trial)
N/A
Recruiting
Led By Philip Chang, DO
Research Sponsored by Cedars-Sinai Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Physically able to complete functional assessments including 6-minute walk test, hand grip strength, short performance physical battery, and performance metrics
Pancreatic cancer diagnosis (any stage)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from baseline to 3 months
Awards & highlights
PREHAB Trial Summary
This trial tests if an exercise program can help people with pancreatic cancer.
Who is the study for?
This trial is for English-speaking adults with pancreatic cancer who can walk and do daily activities on their own. They must be able to perform certain physical tests, have no major restrictions on exercise from their doctor, give written consent, and use a smart device for activity tracking. People who've had or will have surgery before the program ends, are pregnant, or use certain electronic medical devices can't join.Check my eligibility
What is being tested?
The study is testing an exercise program called PREHAB for people with pancreatic cancer. It aims to see if this supervised prehabilitation helps improve patients' fitness levels and overall well-being before they undergo any other treatments.See study design
What are the potential side effects?
Since the intervention involves an exercise program, potential side effects may include typical risks associated with physical activity such as muscle soreness, fatigue, or injury. The specific side effects will depend on each participant's health condition.
PREHAB Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I can perform physical tests like walking, gripping, and other short exercises.
Select...
I have been diagnosed with pancreatic cancer.
Select...
I can walk and take care of my daily needs on my own.
Select...
I can sync a Fitbit and use www.painguide.com on my smart device.
Select...
I am 18 years old or older.
PREHAB Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ from baseline to 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from baseline to 3 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
PREHAB Program feasibility will be measured by tracking participant attendance at PREHAB sessions. PREHAB will be considered feasible if 50% of participants attend at least 60% of scheduled sessions.
Secondary outcome measures
PREHAB Program safety will be assessed through the reporting of unanticipated problems from the baseline visit through to the 3 Month visit.
PREHAB Trial Design
1Treatment groups
Experimental Treatment
Group I: Supervised Prehabilitation Exercise ProgramExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
Cedars-Sinai Medical CenterLead Sponsor
497 Previous Clinical Trials
164,543 Total Patients Enrolled
Philip Chang, DOPrincipal InvestigatorCedars-Sinai Medical Center
1 Previous Clinical Trials
30 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I can perform physical tests like walking, gripping, and other short exercises.I have been diagnosed with pancreatic cancer.Your score on the Godin-Shephard Leisure-Time Physical Activity Questionnaire is 23 or lower.I can walk and take care of my daily needs on my own.I can sync a Fitbit and use www.painguide.com on my smart device.I will have surgery before finishing the PREHAB exercise program.I am 18 years old or older.You have an implanted device like a pacemaker, defibrillator, or neurostimulator, unless the study doctor says it's okay.
Research Study Groups:
This trial has the following groups:- Group 1: Supervised Prehabilitation Exercise Program
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is enrollment open for this medical research endeavor?
"The information on clinicaltrials.gov discloses that this medical experiment is not currently recruiting patients, though it was originally opened for enrollment on April 1st 2023. The last update to the study occurred on January 11th 2023 and there are 694 other trials actively enrolling participants at present."
Answered by AI
Share this study with friends
Copy Link
Messenger